C5841610
influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/South Australia/34/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Injectable Suspension [Fluzone Quadrivalent 2020 Southern Hemisphere]
Concept
Cross-maps
Source vocabularies
Atoms not loaded for this concept.
Related concepts
Common questions
What is the UMLS CUI for influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/South Australia/34/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Injectable Suspension [Fluzone Quadrivalent 2020 Southern Hemisphere]?
influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/South Australia/34/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Injectable Suspension [Fluzone Quadrivalent 2020 Southern Hemisphere] is coded as C5841610 in UMLS.
What is UMLS code C5841610?
C5841610 is the UMLS identifier for influenza A virus A/Brisbane/02/2018 (H1N1) antigen / influenza A virus A/South Australia/34/2019 (H3N2) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Injectable Suspension [Fluzone Quadrivalent 2020 Southern Hemisphere]. It is included in the current NLM UMLS Metathesaurus release.
What is the RxNorm mapping for C5841610?
C5841610 maps to RxNorm 2657753.